The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour

Journal of Clinical Pathology

Volumn 58, Issue 9, 2005, Pages 991-993

  Rossi, G ^a   Sartori, G ^a   Valli, R ^a   Bertolini, F ^a   Bigiani, N ^a   Schirosi, L ^a   Cavazza, A ^b   Luppi, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; IMATINIB; PROTEIN BCL 2; PROTEIN S 100; STEM CELL FACTOR RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CODON; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ECHOGRAPHY; EPITHELIOID SARCOMA; EXON; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; PATHOLOGIST; PRIORITY JOURNAL; STOMACH EPITHELIUM;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HEMANGIOSARCOMA; HUMANS; KERATINS; MUTATION; PELVIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 24644468207     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.024364     Document Type: Article

References (16)

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
2. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
3. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-34.
4. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
5. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61:8118-21.
6. Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-9.
7. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-6.
8. Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-65.
9. Corless C, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813-25.
10. Heinrich MC, Corless C, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-10.
11. Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996;13:297-313.
12. Nga ME, Wong ASC, Wee A, et al. Cytokeratin expression in gastrointestinal stromal tumours: a word of caution. Histopathology 2002;40:480-1.
13. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. A clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001;25:1121-33.
14. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002;117:188-93.
15. Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of c-kit. Mod Pathol 2000;13:536-41.
16. Iijima S, Maesawa C, Sato N, et al. Gastrointestinal stromal tumour of the oesophagus: significance of immunohistochemical and genetic analyses of the c-kit gene. Eur J Gastroenterol Hepatol 2002;14:445-8.